Increased impact of a contraceptive vaginal ring with ethinyl estradiol and nestorone on C-reactive protein

Steroids

Volumn 77, Issue 13, 2012, Pages 1483-1486

  Rad, Mandana ^a   Burggraaf, Jacobus ^a   Sitruk Ware, Regine L ^b   De Kam, Marieke L ^a   Cohen, Adam F ^a   Kluft, Cornelis ^a,c  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b POPULATION COUNCIL   (United States)

^c TNO   (Netherlands)

Author keywords

C reactive protein; Contraceptive vaginal ring; Inflammation; Nestorone; Oral contraceptives

Indexed keywords

C REACTIVE PROTEIN; ELCOMETRINE; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORGESTREL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MENSTRUAL CYCLE; MONOCYTE; ORAL CONTRACEPTION; PREMENOPAUSE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VAGINA RING;

ADOLESCENT; ADULT; C-REACTIVE PROTEIN; CONTRACEPTIVE DEVICES, FEMALE; ETHINYL ESTRADIOL; FEMALE; HUMANS; NORPROGESTERONES; YOUNG ADULT;

EID: 84867590131     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.08.003     Document Type: Article

References (19)

1. W.O. Spitzer, J.M. Faith, and K.D. MacRae Myocardial infarction and third generation oral contraceptives: aggregation of recent studies Hum Reprod. 17 9 2002 2307 2314 (Pubitemid 35021451)
2. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study WHO collaborative study of cardiovascular disease and steroid hormone contraception Lancet 349 9060 1997 1202 1209
3. L. Rosenberg, J.R. Palmer, R.S. Rao, and S. Shapiro Low-dose oral contraceptive use and the risk of myocardial infarction Arch Intern Med 161 8 2001 1065 1070 (Pubitemid 32685532)
4. D.M. Dreon, J.L. Slavin, and S.D. Phinney Oral contraceptive use and increased plasma concentration of C-reactive protein Life Sci 73 10 2003 1245 1252 (Pubitemid 36794589)
5. M. van Rooijen, L.O. Hansson, J. Frostegard, A. Silveira, A. Hamsten, and K. Bremme Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response J Thromb Haemost 4 1 2006 77 82
6. C. Kluft Pro-inflammatory effect of oestrogens Fibrinol Proteol 13 6 1999 217 219 (Pubitemid 30190394)
7. P.M. Ridker, J.E. Buring, N. Rifai, and N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score JAMA 297 6 2007 611 619
8. The effects of seven monophasic oral contraceptive regimens on hemostatic variables Conclusions from a large randomized multicenter study Contraception 67 3 2003 173 185
9. M. Rad, C. Kluft, and J. Menard Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables Am J Obstet Gynecol 195 1 2006 72 77 (Pubitemid 43927505)
10. R.L. Sitruk-Ware, J. Menard, and M. Rad Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen Contraception 75 6 2007 430 437 (Pubitemid 46764302)
11. N. Kumar, S.S. Koide, Y. Tsong, and K. Sundaram Nestorone: a progestin with a unique pharmacological profile Steroids 65 10-11 2000 629 636
12. M.P. de Maat, A.C. de Bart, and B.C. Hennis Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris Arterioscler Thromb Vasc Biol 16 9 1996 1156 1162 (Pubitemid 26299288)
13. D. Aronson, P. Bartha, and O. Zinder Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome Int J Obes Relat Metab Disord 28 5 2004 674 679 (Pubitemid 38580975)
14. I.S. Fraser, M. Lacarra, and D.R. Mishell Vaginal epithelial surface appearances in women using vaginal rings for contraception Contraception 61 2 2000 131 138 (Pubitemid 30236334)
15. T. White, B. Ozel, J.K. Jain, and F.Z. Stanczyk Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins Contraception 74 4 2006 293 296 (Pubitemid 44373883)
16. C. Kluft, P. Meijer, K.D. LaGuardia, and A.C. Fisher Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables Contraception 77 2 2008 77 83
17. V.D. Marinescu, I.S. Kohane, and A. Riva MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes BMC Bioinformatics 6 2005 79
18. D.B. Reuben, S.L. Palla, and P. Hu Progestins affect mechanism of estrogen-induced C-reactive protein stimulation Am J Med 119 2 2006 167, e161-168
19. M. Gol, P. Akan, E. Dogan, C. Karas, U. Saygili, and C. Posaci Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels Maturitas 53 3 2006 252 259 (Pubitemid 43163060)